Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126

Peptides

Volumn 11, Issue 2, 1990, Pages 193-197

  Vesely, David L ^a,b   Cornett, Lawrence E ^a,b   MacLeod, Stewart L ^a,b   Nash, Averie A ^a,b   Norris, James S ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Atrial natriuretic peptides; Binding sites; Prohormone

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR DERIVATIVE; HORMONE PRECURSOR; RADIOISOTOPE;

ANIMAL CELL; ARTICLE; CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ATRIAL NATRIURETIC FACTOR; BINDING, COMPETITIVE; CELL MEMBRANE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMAN; MUSCLE, SMOOTH; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, CELL SURFACE;

ANIMALIA;

EID: 0025264672     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(90)90070-L     Document Type: Article

References (22)

1. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
2. 1-adrenergic receptor subtype in a smooth muscle cell line
3. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria
4. A rapid and potent natriuretic response to the intravenous injection of atrial myocardial extract in rats
5. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves
6. Specific receptors for atrial natriuretic factor (ANF) in cultured vascular smooth muscle cells of rat aorta
7. Secretion of N-terminal fragment of α-human atrial natriuretic polypeptide
8. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility
9. 3H)-spirerone binding to alpha 1-adrenergic receptors in a smooth muscle line
10. Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrialnatriuretic peptide) in cardiac failure and during recumbency
11. Specific membrane receptors for atrial natriuretic factor in renal and vascular tissue
12. 2-adrenergic receptor in a smooth muscle cell line
13. 1 cloned cell line
14. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril (lodogen)
15. Atrial natriuretic prohormone peptides 1–30, 31–67, and 79–98 vasodilate the aorta
16. Prohormone atrial natriuretic peptides 1–30 and 31–67 increase in hyperthyroidism and decrease in hypothyroidism
17. Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans
18. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle
19. Two new hormones: prohormone atrial natriuretic peptides 1–30 and 31–67 circulate in man
20. Circadian rhythm of prohormone atrial natriuretic peptides 1–30, 31–67, and 99–126 in man
21. The N-terminus and a 4000 MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure